Discovery of Potent Inhibitors of Soluble Epoxide Hydrolase by Combinatorial Library Design and Structure-Based Virtual Screening

被引:53
作者
Xing, Li [1 ,2 ]
McDonald, Joseph J. [1 ]
Kolodziej, Steve A. [1 ]
Kurumbail, Ravi G. [1 ]
Williams, Jennifer M. [1 ]
Warren, Chad J. [1 ]
O'Neal, Janet M. [1 ]
Skepner, Jill E. [1 ]
Roberds, Steven L. [1 ]
机构
[1] Pfizer Global Res & Dev, Chesterfield, MO 63017 USA
[2] Pfizer Global Res & Dev, Cambridge, MA 02140 USA
关键词
BIOCHEMICAL-EVIDENCE; CATALYTIC MECHANISM; NITROGEN; DOCKING; INVOLVEMENT; PHOSPHATASE; PREDICTION; EVOLUTION; PATHWAYS; REVEALS;
D O I
10.1021/jm101382t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure-based virtual screening was applied to design combinatorial libraries to discover novel and potent soluble epoxide hydrolase (sEH) inhibitors. X-ray crystal structures revealed unique interactions for a benzoxazole template in addition to the conserved hydrogen bonds with the catalytic machinery of sEH. By exploitation of the favorable binding elements, two iterations of library design based on amide coupling were employed, guided principally by the docking results of the enumerated virtual products. Biological screening of the libraries demonstrated as high as 90% hit rate, of which over two dozen compounds were single digit nanomolar sEH inhibitors by 105,0 determination. In total the library design and synthesis produced more than 300 submicromolar sEH inhibitors. In cellular systems consistent activities were demonstrated with biochemical measurements. The SAR understanding of the benzoxazole template provides valuable insights into discovery of novel sEH inhibitors as therapeutic agents.
引用
收藏
页码:1211 / 1222
页数:12
相关论文
共 39 条
[1]  
[Anonymous], PYMOL MOL GRAPH SYST
[2]   Epoxide hydrolases: Structure, function, mechanism, and assay [J].
Arand, M ;
Cronin, A ;
Adamska, M ;
Oesch, F .
PHASE II CONJUGATION ENZYMES AND TRANSPORT SYSTEMS, 2005, 400 :569-588
[3]  
Arand M, 1996, J BIOL CHEM, V271, P4223
[4]   Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation [J].
Argiriadi, MA ;
Morisseau, C ;
Goodrow, MH ;
Dowdy, DL ;
Hammock, BD ;
Christianson, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :15265-15270
[5]   Detoxification of environmental mutagens and carcinogens: Structure, mechanism, and evolution of liver epoxide hydrolase [J].
Argiriadi, MA ;
Morisseau, C ;
Hammock, BD ;
Christianson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10637-10642
[6]   Oxygen and nitrogen in competitive situations: Which is the hydrogen-bond acceptor? [J].
Bohm, HJ ;
Brode, S ;
Hesse, U ;
Klebe, G .
CHEMISTRY-A EUROPEAN JOURNAL, 1996, 2 (12) :1509-1513
[7]   MECHANISM OF SOLUBLE EPOXIDE HYDROLASE - FORMATION OF AN ALPHA-HYDROXY ESTER-ENZYME INTERMEDIATE THROUGH ASP-333 [J].
BORHAN, B ;
JONES, AD ;
PINOT, F ;
GRANT, DF ;
KURTH, MJ ;
HAMMOCK, BD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) :26923-26930
[8]   The soluble epoxide hydrolase as a pharmaceutical target for hypertension [J].
Chiamvimonvat, Nipavan ;
Ho, Chin-Min ;
Tsai, Hsing-Ju ;
Hammock, Bruce D. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (03) :225-237
[9]   Insights into the Catalytic Mechanism of Human sEH Phosphatase by Site-Directed Mutagenesis and LC-MS/MS Analysis [J].
Cronin, Annette ;
Homburg, Shirli ;
Duerk, Heike ;
Richter, Ingrid ;
Adamskal, Magdalena ;
Frere, Frederic ;
Arand, Michael .
JOURNAL OF MOLECULAR BIOLOGY, 2008, 383 (03) :627-640
[10]   Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase [J].
Eldrup, Anne B. ;
Soleymanzadeh, Fariba ;
Farrow, Neil A. ;
Kukulka, Alison ;
De Lombaert, Stephane .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) :571-575